Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
The metabolic syndrome of vascular risk is threatening large numbers of ever-younger people. To date, the syndrome has been chiefly viewed as a potential risk marker that confers a heightened probability of developing type 2 diabetes and occlusive atherothrombotic disease of large- and medium-sized...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2009-10.
|
Subjects: | |
Online Access: | Get fulltext |